- Company Overview for LONDONPHARMA LIMITED (06392197)
- Filing history for LONDONPHARMA LIMITED (06392197)
- People for LONDONPHARMA LIMITED (06392197)
- More for LONDONPHARMA LIMITED (06392197)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
17 Jan 2024 | TM02 | Termination of appointment of Clyde Secretaries Limited as a secretary on 17 January 2024 | |
16 Jan 2024 | DISS16(SOAS) | Compulsory strike-off action has been suspended | |
21 Nov 2023 | GAZ1 | First Gazette notice for compulsory strike-off | |
24 Oct 2023 | TM01 | Termination of appointment of Rosie Featherby as a director on 19 October 2023 | |
07 Mar 2023 | DISS40 | Compulsory strike-off action has been discontinued | |
06 Mar 2023 | AA | Total exemption full accounts made up to 31 December 2021 | |
28 Feb 2023 | GAZ1 | First Gazette notice for compulsory strike-off | |
07 Sep 2022 | CS01 | Confirmation statement made on 3 September 2022 with no updates | |
31 Mar 2022 | AA | Total exemption full accounts made up to 31 December 2020 | |
06 Sep 2021 | CS01 | Confirmation statement made on 3 September 2021 with no updates | |
03 Sep 2020 | CS01 | Confirmation statement made on 3 September 2020 with no updates | |
16 Jun 2020 | AA | Micro company accounts made up to 31 December 2019 | |
16 Jan 2020 | AP01 | Appointment of Ms Rosie Featherby as a director on 16 January 2020 | |
16 Jan 2020 | TM01 | Termination of appointment of Glenn Robert Featherby as a director on 16 January 2020 | |
15 Oct 2019 | AA | Micro company accounts made up to 31 December 2018 | |
04 Sep 2019 | CS01 | Confirmation statement made on 3 September 2019 with updates | |
03 Dec 2018 | AA | Total exemption full accounts made up to 31 December 2017 | |
06 Sep 2018 | CS01 | Confirmation statement made on 3 September 2018 with no updates | |
20 Sep 2017 | AA | Total exemption full accounts made up to 31 December 2016 | |
04 Sep 2017 | CS01 | Confirmation statement made on 3 September 2017 with updates | |
31 Mar 2017 | AP01 | Appointment of Glenn Robert Featherby as a director on 31 March 2017 | |
31 Mar 2017 | TM01 | Termination of appointment of David Laskow-Pooley as a director on 31 March 2017 | |
31 Mar 2017 | TM01 | Termination of appointment of Carmen Timis as a director on 31 March 2017 | |
31 Mar 2017 | TM01 | Termination of appointment of Christopher William Duffy as a director on 31 March 2017 | |
12 Jan 2017 | SH01 |
Statement of capital following an allotment of shares on 15 December 2016
|